Kruse A, Astrup J, Gyldensted C, Cold G E
Department of Neurosurgery, Aarhus University Hospital, Denmark.
Br J Neurosurg. 1995;9(4):453-7. doi: 10.1080/02688699550041089.
Hyperprolactinaemia, unexplained by prolactin-production of the tumour is occasionally found in patients with pituitary tumours. This secondary hyperprolactinaemia has been ascribed to a mass effect of the tumour upon the pituitary stalk, obstructing the normal inhibitory hypothalamic influence on the prolactin producing cells. In this study the adenoma volume, amount of suprasellar enlargement of the tumour and the intrasellar pressure were measured in 42 patients operated upon consecutively for pituitary tumours. Secondary hyperprolactinaemia was found in six (14%). There was no difference as regards adenoma volume, amount of suprasellar extension or intrasellar pressure between the group of patients with elevated p-prolactin versus the group with normal p-prolactin. We conclude that mechanisms other than pituitary stalk compression must be considered as the cause of secondary hyperprolactinaemia.
在垂体瘤患者中,偶尔会发现无法用肿瘤产生催乳素来解释的高催乳素血症。这种继发性高催乳素血症被归因于肿瘤对垂体柄的占位效应,阻碍了下丘脑对催乳素分泌细胞的正常抑制作用。在本研究中,对42例因垂体瘤连续接受手术的患者测量了腺瘤体积、肿瘤鞍上扩大程度和鞍内压力。发现6例(14%)有继发性高催乳素血症。催乳素升高组与催乳素正常组在腺瘤体积、鞍上延伸程度或鞍内压力方面没有差异。我们得出结论,必须考虑垂体柄受压以外的机制作为继发性高催乳素血症的原因。